2008 Free to Breathe Fellowship Award/Young Investigators Award
Ilse Valencia,
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center
Research Project:
Drug-Resistant Tumors
Summary:
Dr. Valencia is seeking to understand how some non-small-cell lung cancer (NSCLC) tumors become resistant to drugs like erlotinib (Tarceva) that target the epidermal growth factor receptor (EGFR).